| [1] |
JIANG Haitao, XU Yangxian .
Research progress on the resistance mechanism of anti-angiogenesis targeted drugs in the treatment of colorectal cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(2): 193-199.
|
| [2] |
KE Jiajie, SHEN Yuzhou, XU Yaping, CHEN Yupei, CHEN Peiyuan, WU Hongtan.
Effects and mechanism of ethanol extract of Angelica sinensis (Oliv.) Diels on cell proliferation inhibition and apoptosis induction in B16-F10 melanoma cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2025, 30(1): 51-60.
|
| [3] |
Celimuge, Hudeligen, XU Liang.
Network pharmacology-molecular docking analysis and experimental validation to explore the protective mechanism of Mongolian medicine Gaoyou on renal function
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(9): 968-978.
|
| [4] |
JIN Baowei, WANG Kai, GUO Jianrong.
Research progress on the effects of propofol on tumor growth and metastasis mechanism
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(9): 1042-1048.
|
| [5] |
ZHU Changmao, XIE Li, WU Zifeng, WANG Sen, ZHANG Qi, XU Xiangqing, YANG Chun.
Progress in the clinical application of the biased μ-opioid agonist oliceridine
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(9): 1057-1061.
|
| [6] |
LI Nana, LI Zijian.
Advances in the study of acquired FXIII deficiency
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(9): 1070-1075.
|
| [7] |
WANG Dan, ZHANG Wenyan, LUO Renjie, CHEN Yuanjing, HAN Xue, QU Bo, FENG Shifang, NIE Xiazi, LIU Huiling.
Research progress of molecular docking in screening anti-cervical cancer drugs
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(8): 955-960.
|
| [8] |
LIU Shuang, JIANG Hanchun, WU Jingjing, ZHAO Rongsheng.
Umbrella review of the efficacy and safety of monoclonal antibodies in the treatment of thyroid-associated ophthalmopathy
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(7): 735-743.
|
| [9] |
ZHANG Li, LU Chang, AN Minghui, WANG Mengmeng, ZONG Xiaoyu, YU Lin, RAN Zhuo-ling, SONG Jing, LI Huijie, GONG Jian.
Mechanism of action and research progress of vaccine adjuvants
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(7): 785-791.
|
| [10] |
LI Zepeng, GU Wenqiang, CHEN Xiao, WANG Yinhua, LI Xianwei.
Protective efficacy of epalrestat on mitochondrial oxidative stress damage for radiation pneumonitis in mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(7): 809-818.
|
| [11] |
ZHANG Xiaowei, WANG Nan, DAI Mengge, LIU Ruijuan, MA Ting.
Research progress on material basis and mechanism of Hedyotis Diffusa-Scutellaria Barbata Herb Pair in the treatment of gastric cancer
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(7): 831-840.
|
| [12] |
ZHANG Ting, SUN Rong, YANG Yong, LIU Weichun, YUAN Yuping, JU Xu, WANG Qian.
Mechanism and treatment of mucous hypersecretion in chronic obstructive pulmonary disease
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(4): 383-391.
|
| [13] |
ZHAO Tingting, LI Junfeng, ZHANG Liting.
Progress in the potential therapeutic mechanism of mesenchymal stem cell-derived exosomes for liver fibrosis
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(4): 475-480.
|
| [14] |
WU Xingdong, YUE Hongmei, ZHU Haobin, LIU Miaomiao, LI Yating, XU Jinhui.
Research progress of pharmacologic therapy in obstructive sleep apnea
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(2): 215-229.
|
| [15] |
LIN Xinyue, WANG Yanyan, BIAN Hongsheng, YU Shuang, HUANG Lili.
Research progress on physiological and pathological functions of salt-inducible kinase and its inhibitors
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2024, 29(11): 1306-1314.
|